140 related articles for article (PubMed ID: 26196226)
41. Impact of initiating insulin glargine disposable pen versus vial/syringe on real-world glycemic outcomes and persistence among patients with type 2 diabetes mellitus in a large managed care plan: a claims database analysis.
Xie L; Zhou S; Pinsky BW; Buysman EK; Baser O
Diabetes Technol Ther; 2014 Sep; 16(9):567-75. PubMed ID: 24735083
[TBL] [Abstract][Full Text] [Related]
42. Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians.
Brod M; Rana A; Barnett AH
Curr Med Res Opin; 2012 Dec; 28(12):1947-58. PubMed ID: 23150950
[TBL] [Abstract][Full Text] [Related]
43. Dosing irregularities and self-treated hypoglycemia in type 2 diabetes: results from the Canadian cohort of an international survey of patients and healthcare professionals.
Leiter LA; Boras D; Woo VC
Can J Diabetes; 2014 Feb; 38(1):38-44. PubMed ID: 24485212
[TBL] [Abstract][Full Text] [Related]
44. Severe hypoglycemia in the Look AHEAD Trial.
; Greenway FL
J Diabetes Complications; 2016 Jul; 30(5):935-43. PubMed ID: 27114389
[TBL] [Abstract][Full Text] [Related]
45. The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients.
Williams SA; Shi L; Brenneman SK; Johnson JC; Wegner JC; Fonseca V
J Diabetes Complications; 2012; 26(5):399-406. PubMed ID: 22699113
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of the cost-utility of insulin degludec vs insulin glargine in Sweden.
Ericsson Å; Pollock RF; Hunt B; Valentine WJ
J Med Econ; 2013 Dec; 16(12):1442-52. PubMed ID: 24147661
[TBL] [Abstract][Full Text] [Related]
47. Economic impact of hypoglycemia among insulin-treated patients with diabetes.
Sussman M; Sierra JA; Garg S; Bode B; Friedman M; Gill M; Kaufman F; Vigersky R; Menzin J
J Med Econ; 2016 Nov; 19(11):1099-1106. PubMed ID: 27292016
[TBL] [Abstract][Full Text] [Related]
48. Important Decrease in Hospitalizations for Acute Diabetes Events Following FreeStyle Libre System Initiation in People with Type 2 Diabetes on Basal Insulin Therapy in France.
Guerci B; Roussel R; Levrat-Guillen F; Detournay B; Vicaut E; De Pouvourville G; Emery C; Riveline JP
Diabetes Technol Ther; 2023 Jan; 25(1):20-30. PubMed ID: 36094418
[No Abstract] [Full Text] [Related]
49. Insulin dosing and outcomes among commercially insured patients with type 2 diabetes in the United States.
Eby EL; Van Brunt K; Brusko C; Curtis B; Lage MJ
Clin Ther; 2015 Oct; 37(10):2297-2308.e1. PubMed ID: 26341171
[TBL] [Abstract][Full Text] [Related]
50. Risk prediction for severe hypoglycemia in a type 2 diabetes population with previous non-severe hypoglycemia.
Misra-Hebert AD; Ji X; Pantalone KM; Hu B; Dey T; Milinovich A; Bauman JM; Zimmerman RS; Kattan MW
J Diabetes Complications; 2020 Jan; 34(1):107490. PubMed ID: 31757766
[TBL] [Abstract][Full Text] [Related]
51. A model of mild hypoglycemia.
Samuel S; Goswami D; Shum K; Boye KS; Rengarajan B; Curtis B; Curtis SE
Curr Med Res Opin; 2015 Apr; 31(4):633-41. PubMed ID: 25690489
[TBL] [Abstract][Full Text] [Related]
52. Biopsychobehavioral model of risk of severe hypoglycemia. Self-management behaviors.
Clarke WL; Cox DJ; Gonder-Frederick L; Julian D; Kovatchev B; Young-Hyman D
Diabetes Care; 1999 Apr; 22(4):580-4. PubMed ID: 10189535
[TBL] [Abstract][Full Text] [Related]
53. Previously unrecognized risk factors for severe hypoglycaemia requiring emergency medical care in insulin-treated type 2 diabetes: Results from a real-world nested case-control study.
Settles J; Kan H; Child CJ; Gorritz M; Multani JK; McGuiness CB; Wade RL; Frier BM
Diabetes Obes Metab; 2022 Jul; 24(7):1235-1244. PubMed ID: 35266273
[TBL] [Abstract][Full Text] [Related]
54. Factors that drive insulin-dosing decisions of diabetes care providers: a vignette-based study in the Netherlands.
Simon AC; Schopman JE; Hoekstra JB; Abu-Hanna A; Gerdes VE; Peek N; Holleman F
Diabet Med; 2015 Jan; 32(1):69-77. PubMed ID: 25204362
[TBL] [Abstract][Full Text] [Related]
55. Association between hypoglycemia and fall-related events in type 2 diabetes mellitus: analysis of a U.S. commercial database.
Kachroo S; Kawabata H; Colilla S; Shi L; Zhao Y; Mukherjee J; Iloeje U; Fonseca V
J Manag Care Spec Pharm; 2015 Mar; 21(3):243-53. PubMed ID: 25726033
[TBL] [Abstract][Full Text] [Related]
56. PREVENTION AND MANAGEMENT OF INSULIN-ASSOCIATED HYPOGLYCEMIA IN HOSPITALIZED PATIENTS.
Mathioudakis N; Everett E; Golden SH
Endocr Pract; 2016 Aug; 22(8):959-69. PubMed ID: 27042740
[TBL] [Abstract][Full Text] [Related]
57. Prediction of severe hypoglycemia.
Cox DJ; Gonder-Frederick L; Ritterband L; Clarke W; Kovatchev BP
Diabetes Care; 2007 Jun; 30(6):1370-3. PubMed ID: 17363757
[TBL] [Abstract][Full Text] [Related]
58. Trends of severe hypoglycemia in patients with type 2 diabetes in Korea: A longitudinal nationwide cohort study.
Yun JS; Han K; Ko SH
J Diabetes Investig; 2022 Aug; 13(8):1438-1443. PubMed ID: 35263509
[TBL] [Abstract][Full Text] [Related]
59. Prediction and prevention of treatment-related inpatient hypoglycemia.
Elliott MB; Schafers SJ; McGill JB; Tobin GS
J Diabetes Sci Technol; 2012 Mar; 6(2):302-9. PubMed ID: 22538139
[TBL] [Abstract][Full Text] [Related]
60. Outcomes and healthcare resource utilization associated with medically attended hypoglycemia in older patients with type 2 diabetes initiating basal insulin in a US managed care setting.
Escalada J; Liao L; Pan C; Wang H; Bala M
Curr Med Res Opin; 2016 Sep; 32(9):1557-65. PubMed ID: 27173946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
